Literature DB >> 24829469

Clinical considerations and mechanistic determinants of postprandial lipemia in older adults.

Christos S Katsanos1.   

Abstract

The typical diet of individuals in Western societies results in metabolic responses associated with fed-state fat metabolism for most of the daily life of the individual. This fat metabolism is characterized specifically by an increase in the concentration of plasma lipids, primarily triglycerides. Increased postprandial lipemia, which is typically observed in older individuals (i.e., >65 y old), has now emerged as an important correlate of cardiovascular disease risk. An understanding of the mechanisms contributing to the increased postprandial lipemia in older individuals becomes, therefore, of particular clinical importance in any effort to explain and address the well-documented increase in cardiovascular disease risk as individuals age. Current evidence points to an increase in the accumulation of ingested lipid in lipoprotein particles of hepatic origin, together with an overall accumulation of lipid in these lipoproteins during the postprandial period, as primary contributors to the postprandial lipemia in older persons. When this evidence is considered together with the evidence suggesting large atherogenic potential of lipoproteins of hepatic origin, this can, at least in part, explain the increased risk of cardiovascular disease in older individuals. Understanding changes in the metabolism of ingested fat in the immediate postprandial period with advancing age, and how lifestyle interventions such as diet and physical exercise can ameliorate the increase in postprandial lipemia in older individuals, is important in order to address the increased cardiovascular disease risk in this particularly affected and growing segment of the population.
© 2014 American Society for Nutrition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24829469      PMCID: PMC4013175          DOI: 10.3945/an.113.004903

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  67 in total

Review 1.  Age-related changes in the liver sinusoidal endothelium: a mechanism for dyslipidemia.

Authors:  David G LE Couteur; Victoria C Cogger; Robert S McCuskey; Rafael DE Cabo; Bârd Smedsrød; Karen K Sorensen; Alessandra Warren; Robin Fraser
Journal:  Ann N Y Acad Sci       Date:  2007-09-05       Impact factor: 5.691

Review 2.  Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?

Authors:  K N Frayn; C M Williams; P Arner
Journal:  Clin Sci (Lond)       Date:  1996-04       Impact factor: 6.124

3.  ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases.

Authors:  Katsuyuki Nakajima; Yasuhiro Nakajima; Sanae Takeichi; Masaki Q Fujita
Journal:  Atherosclerosis       Date:  2006-10-11       Impact factor: 5.162

4.  Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates.

Authors:  W S Harris; F Muzio
Journal:  Am J Clin Nutr       Date:  1993-07       Impact factor: 7.045

5.  Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.

Authors:  J S Millar; A H Lichtenstein; M Cuchel; G G Dolnikowski; D L Hachey; J S Cohn; E J Schaefer
Journal:  J Lipid Res       Date:  1995-06       Impact factor: 5.922

6.  Postprandial lipemia associates with liver fat content.

Authors:  Niina Matikainen; Sakari Mänttäri; Jukka Westerbacka; Satu Vehkavaara; Nina Lundbom; Hannele Yki-Järvinen; Marja-Riitta Taskinen
Journal:  J Clin Endocrinol Metab       Date:  2007-05-08       Impact factor: 5.958

7.  Splanchnic spillover of extracellular lipase-generated fatty acids in overweight and obese humans.

Authors:  Robert H Nelson; Rita Basu; C Michael Johnson; Robert A Rizza; John M Miles
Journal:  Diabetes       Date:  2007-09-19       Impact factor: 9.461

8.  Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans.

Authors:  B O Schneeman; L Kotite; K M Todd; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

Authors:  Børge G Nordestgaard; Marianne Benn; Peter Schnohr; Anne Tybjaerg-Hansen
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

10.  Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.

Authors:  H M Krumholz; T E Seeman; S S Merrill; C F Mendes de Leon; V Vaccarino; D I Silverman; R Tsukahara; A M Ostfeld; L F Berkman
Journal:  JAMA       Date:  1994-11-02       Impact factor: 56.272

View more
  4 in total

1.  Postprandial Metabolic Responses Differ by Age Group and Physical Activity Level.

Authors:  S R Emerson; S P Kurti; E M Emerson; B J Cull; K Casey; M D Haub; S K Rosenkranz
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 2.  Influence on Adiposity and Atherogenic Lipaemia of Fatty Meals and Snacks in Daily Life.

Authors:  Antonio Laguna-Camacho
Journal:  J Lipids       Date:  2017-06-19

3.  Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study.

Authors:  Shujie Wang; Huahui Ren; Huanzi Zhong; Xinjie Zhao; Changkun Li; Jing Ma; Xuejiang Gu; Yaoming Xue; Shan Huang; Jialin Yang; Li Chen; Gang Chen; Shen Qu; Jun Liang; Li Qin; Qin Huang; Yongde Peng; Qi Li; Xiaolin Wang; Yuanqiang Zou; Zhun Shi; Xuelin Li; Tingting Li; Huanming Yang; Shenghan Lai; Guowang Xu; Junhua Li; Yifei Zhang; Yanyun Gu; Weiqing Wang
Journal:  Gut Microbes       Date:  2022 Jan-Dec

4.  Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trial.

Authors:  Rodney A Velliquette; Kerry Grann; Stephen R Missler; Jennifer Patterson; Chun Hu; Kevin W Gellenbeck; Jeffrey D Scholten; R Keith Randolph
Journal:  Nutr Metab (Lond)       Date:  2015-08-06       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.